Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)

Phase Distribution

Ph not_applicable
5
63%
Ph phase_2
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(3)
Terminated(1)
Other(4)

Detailed Status

unknown4
Completed3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (16.7%)
N/A5 (83.3%)

Trials by Status

unknown450%
completed338%
withdrawn113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
8